G21A (p.Gly21Ala) variant of KRT17 (Keratin, type I cytoskeletal 17)

G21A (p.Gly21Ala) in KRT17 (Keratin, type I cytoskeletal 17) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

G21A (p.Gly21Ala) variant details